|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0019134,
umls-concept:C0019139,
umls-concept:C0019994,
umls-concept:C0042487,
umls-concept:C0087111,
umls-concept:C0348016,
umls-concept:C0443315,
umls-concept:C1257890,
umls-concept:C1521801,
umls-concept:C1707455,
umls-concept:C2603343
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
1996-4-11
|
|
pubmed:abstractText |
An intravenous course of standard (unfractionated) heparin with the dose adjusted to prolong the activated partial-thromboplastin time to a desired length is the standard initial in-hospital treatment for patients with deep-vein thrombosis, but fixed-dose subcutaneous low-molecular-weight heparin appears to be as effective and safe. Because the latter treatment can be given on an outpatient basis, we compared the two treatments in symptomatic outpatients with proximal-vein thrombosis but no signs of pulmonary embolism.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0028-4793
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
14
|
|
pubmed:volume |
334
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
682-7
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8594426-Aged,
pubmed-meshheading:8594426-Anticoagulants,
pubmed-meshheading:8594426-Female,
pubmed-meshheading:8594426-Hemorrhage,
pubmed-meshheading:8594426-Heparin,
pubmed-meshheading:8594426-Home Nursing,
pubmed-meshheading:8594426-Hospitalization,
pubmed-meshheading:8594426-Humans,
pubmed-meshheading:8594426-Infusions, Intravenous,
pubmed-meshheading:8594426-Injections, Subcutaneous,
pubmed-meshheading:8594426-Length of Stay,
pubmed-meshheading:8594426-Male,
pubmed-meshheading:8594426-Middle Aged,
pubmed-meshheading:8594426-Nadroparin,
pubmed-meshheading:8594426-Quality of Life,
pubmed-meshheading:8594426-Recurrence,
pubmed-meshheading:8594426-Self Administration,
pubmed-meshheading:8594426-Thromboembolism,
pubmed-meshheading:8594426-Thrombosis,
pubmed-meshheading:8594426-Treatment Outcome
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group.
|
|
pubmed:affiliation |
Academic Medical Center, Amsterdam, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
